Pneumonia, Viral (drug therapy) And NotWu Zhong
List of bibliographic references
Number of relevant bibliographic references: 16.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000007 | X. Yuan [République populaire de Chine] ; J S Mu [République populaire de Chine] ; G X Mo [République populaire de Chine] ; X S Hu [République populaire de Chine] ; P. Yan [République populaire de Chine] ; L X Xie [République populaire de Chine] | [Respiratory support for severe 2019-nCoV pneumonia suffering from acute respiratory failure: time and strategy]. |
| 000014 | H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000015 | Y N Liu [République populaire de Chine] | [Pharmacotherapeutic about the new coronavirus pneumonia]. |
| 000023 | J P Zhao ; Y. Hu ; R H Du ; Z S Chen ; Y. Jin ; M. Zhou ; J. Zhang ; J M Qu ; B. Cao | [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]. |
| 000027 | L. Zhou [République populaire de Chine] ; H G Liu | [Early detection and disease assessment of patients with novel coronavirus pneumonia]. |
| 000089 | David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000092 | Robert L. Kruse [États-Unis] | Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. |
| 000094 | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
| 000154 | Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis] | Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
| 000280 | Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000312 | Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
| 000342 | Deng-Hai Zhang [République populaire de Chine] ; Kun-Lun Wu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Sheng-Qiong Deng [République populaire de Chine] ; Bin Peng [République populaire de Chine] | In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. |
| 000427 | Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
| 000428 | Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi | Drug targets for corona virus: A systematic review |
| 000529 | Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. |
| 000537 | Ewen Callaway ; David Cyranoski | China coronavirus: Six questions scientists are asking. |
| This area was generated with Dilib version V0.6.33. |  |